published meta-analysis   sensitivity analysis   studies

face mask in preventing respiratory virus transmission - Summary of results

OutcomeTE95% CInkI2ROBPub. bias Influenza-like infectiondetailed resultsAiello, 2010 0.78 [0.52; 1.15] Aiello, 2012 0.25 [0.07; 0.88] Alfelali, 2019 1.10 [0.88; 1.38] Barasheed, 2014 0.41 [0.17; 0.99] Canini, 2010 1.03 [0.56; 1.90] Cowling, 2008 2.20 [0.69; 6.99] Cowling, 2009 0.85 [0.28; 2.57] Larson, 2010 0.87 [0.65; 1.16] MacIntyre, 2009 1.33 [0.64; 2.77] MacIntyre, 2016 0.32 [0.03; 3.13] Simmerman, 2011 1.03 [0.67; 1.58] Suess, 2012 0.46 [0.17; 1.28] 0.89[0.73; 1.10]Aiello, 2010, Aiello, 2012, Alfelali, 2019, Barasheed, 2014, Canini, 2010, Cowling, 2008, Cowling, 2009, Larson, 2010, MacIntyre, 2009, MacIntyre, 2016, Simmerman, 2011, Suess, 20121234%9,769NAlow respiratory viral infectionsdetailed resultsAiello, 2012 0.70 [0.33; 1.50] Barasheed, 2014 3.19 [0.55; 18.42] Cowling, 2008 1.13 [0.35; 3.63] Cowling, 2009 0.67 [0.36; 1.25] MacIntyre, 2011 0.57 [0.30; 1.09] Suess, 2012 0.32 [0.12; 0.84] 0.67[0.45; 0.98]Aiello, 2012, Barasheed, 2014, Cowling, 2008, Cowling, 2009, MacIntyre, 2011, Suess, 2012620%3,727NAnot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-04-16 23:06 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 99 - treatments: 629 - roots T: 290